BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 16523419)

  • 1. Nephrology: main advances in the last 40 years.
    Locatelli F; Del Vecchio L; Pozzoni P; Manzoni C
    J Nephrol; 2006; 19(1):6-11. PubMed ID: 16523419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nephrology and renal replacement therapy in Romania--transition still continues (Cinderella story revisited).
    Mircescu G; Capsa D; Covic M; Caprioara MG; Gluhovschi G; Golea O; Ursea N; Gârneata L; Cepoi V; Constantinovici N; Covic A
    Nephrol Dial Transplant; 2004 Dec; 19(12):2971-80. PubMed ID: 15574995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End-stage renal disease and its treatment in Latin America in the twenty-first century.
    Cusumano A; Garcia-Garcia G; Di Gioia C; Hermida O; Lavorato C; Carreño CA; Torrico MP; Batista PB; Romão JE; Badal HP; Miranda SE; Gomez R; Calderon MC; Sanchez SH; Lopez MA; Moscoso J; Merino RL; Polo JV; Lopez A; Romero NJ; Garcia R; Acosta BV; Lopez AS; Delpin ES; Mena E; González C; Milanés CL; Acchiardo S
    Ren Fail; 2006; 28(8):631-7. PubMed ID: 17162420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. End-stage renal disease in Indonesia: treatment development.
    Prodjosudjadi W; Suhardjono A
    Ethn Dis; 2009; 19(1 Suppl 1):S1-33-6. PubMed ID: 19484872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in renal replacement therapy in Turkey, 1996-2008.
    Süleymanlar G; Serdengeçti K; Altiparmak MR; Jager K; Seyahi N; Erek E;
    Am J Kidney Dis; 2011 Mar; 57(3):456-65. PubMed ID: 21335249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors affecting survival in advanced chronic kidney disease patients who choose not to receive dialysis.
    Wong CF; McCarthy M; Howse ML; Williams PS
    Ren Fail; 2007; 29(6):653-9. PubMed ID: 17763158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elderly diabetic patients on peritoneal dialysis.
    Passadakis P; Oreopoulos DG
    Adv Perit Dial; 2009; 25():140-6. PubMed ID: 19886336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal replacement therapy in the Canary Islands: demographic and survival analysis.
    Lorenzo V; Sanchez E; Vega N; Hernandez D
    J Nephrol; 2006; 19(1):97-103. PubMed ID: 16523433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nephrology in Tunisia: From yesterday to now].
    Ben Maïz H
    Nephrol Ther; 2010 Jun; 6(3):173-8. PubMed ID: 20399171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidemiology and demography of uremia: data from the Lombardy Dialysis and Transplantation Registry (RLDT)].
    Limido A; Malberti F; Conte F; Spotti D; Locatelli F
    G Ital Nefrol; 2005; 22 Suppl 31():S3-8. PubMed ID: 15786398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. History of nephrology and renal replacement therapy in Korea.
    Lee HB
    J Nephrol; 2011; 24 Suppl 17():S93-6. PubMed ID: 21614787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease.
    Conway B; Webster A; Ramsay G; Morgan N; Neary J; Whitworth C; Harty J
    Nephrol Dial Transplant; 2009 Jun; 24(6):1930-7. PubMed ID: 19181760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidence, prevalence, treatment and cost of end-stage renal disease in Indonesia.
    Prodjosudjadi W
    Ethn Dis; 2006; 16(2 Suppl 2):S2-14-6. PubMed ID: 16774003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [World kidney Day 2008: the impact of epidemiology of kidney diseases in Belgium].
    Nortier J; Peeters P; Collart F; Des Grottes JM; Pochet JM; ;
    Rev Med Brux; 2008; 29(1 Suppl):S19-24. PubMed ID: 18497216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prospective evaluation of renal replacement therapy modality eligibility.
    Mendelssohn DC; Mujais SK; Soroka SD; Brouillette J; Takano T; Barre PE; Mittal BV; Singh A; Firanek C; Story K; Finkelstein FO
    Nephrol Dial Transplant; 2009 Feb; 24(2):555-61. PubMed ID: 18755848
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current status of end-stage renal disease care in South Asia.
    Jha V
    Ethn Dis; 2009; 19(1 Suppl 1):S1-27-32. PubMed ID: 19484871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of gender, age, and geographical location on the incidence and prevalence of renal replacement therapy in Wales.
    van Woerden HC; Wilkinson J; Heaven M; Merrifield J
    BMC Nephrol; 2007 Jan; 8():1. PubMed ID: 17217542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of management and treatment responses in haemodialysis patients from Tehran province, Iran.
    Mahdavi-Mazdeh M; Zamyadi M; Nafar M
    Nephrol Dial Transplant; 2008 Jan; 23(1):288-93. PubMed ID: 17965435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The start of clinical nephrology in Austria and developments in the treatment of patients with end stage renal disease over the last decades.
    Watschinger B; Watschinger B
    Wien Klin Wochenschr; 1997 Jun; 109(12-13):499-503. PubMed ID: 9261994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patients with end stage renal disease: a registry at Sultanah Aminah Hospital, Johor Bahru, Malaysia.
    Liu WJ; Hooi LS
    Med J Malaysia; 2007 Aug; 62(3):197-200. PubMed ID: 18246906
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.